Segui
Matthew W. Johnson
Matthew W. Johnson
Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University
Email verificata su jhu.edu - Home page
Titolo
Citata da
Citata da
Anno
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson, MA Carducci, A Umbricht, WA Richards, ...
Journal of Psychopharmacology 30 (12), 1181-1197, 2016
23232016
Human hallucinogen research: guidelines for safety
MW Johnson, WA Richards, RR Griffiths
Journal of Psychopharmacology 22 (6), 603-620, 2008
13482008
Within‐subject comparison of real and hypothetical money rewards in delay discounting
MW Johnson, WK Bickel
Journal of the experimental analysis of behavior 77 (2), 129-146, 2002
12912002
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse
Journal of psychopharmacology 22 (6), 621-632, 2008
12162008
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA psychiatry 78 (5), 481-489, 2021
12062021
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths
Journal of Psychopharmacology 28 (11), 983-992, 2014
11242014
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards, BD Richards, U McCann, ...
Psychopharmacology 218, 649-665, 2011
10912011
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson, RR Griffiths
Journal of Psychopharmacology 25 (11), 1453-1461, 2011
10612011
Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude.
F Baker, MW Johnson, WK Bickel
Journal of abnormal psychology 112 (3), 382, 2003
7902003
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu, RR Griffiths
The American journal of drug and alcohol abuse 43 (1), 55-60, 2017
7432017
The behavioral economics of substance use disorders: reinforcement pathologies and their repair
WK Bickel, MW Johnson, MN Koffarnus, J MacKillop, JG Murphy
Annual review of clinical psychology 10, 641-677, 2014
7072014
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, R R Griffiths, M W Johnson
Current drug abuse reviews 7 (3), 157-164, 2014
6042014
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
FS Barrett, MW Johnson, RR Griffiths
Journal of Psychopharmacology 29 (11), 1182-1190, 2015
5892015
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and …
RR Griffiths, MW Johnson, WA Richards, BD Richards, R Jesse, ...
Journal of Psychopharmacology 32 (1), 49-69, 2018
5862018
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
TM Carbonaro, MP Bradstreet, FS Barrett, KA MacLean, R Jesse, ...
Journal of Psychopharmacology 30 (12), 1268-1278, 2016
5842016
An algorithm for identifying nonsystematic delay-discounting data.
MW Johnson, WK Bickel
Experimental and clinical psychopharmacology 16 (3), 264, 2008
5632008
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
MW Johnson, PS Hendricks, FS Barrett, RR Griffiths
Pharmacology & therapeutics 197, 83-102, 2019
5332019
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
PS Hendricks, CB Thorne, CB Clark, DW Coombs, MW Johnson
Journal of Psychopharmacology 29 (3), 280-288, 2015
4752015
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos, MW Johnson, RR Griffiths
Journal for the scientific study of religion 51 (4), 721-737, 2012
4632012
Psychedelics as medicines: an emerging new paradigm
DE Nichols, MW Johnson, CD Nichols
Clinical Pharmacology & Therapeutics 101 (2), 209-219, 2017
4062017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20